Rituximab for the treatment of corticosteroid-refractory chronic graft-versus-host disease.
Teshima, Takanori
Rituximab for the treatment of corticosteroid-refractory chronic graft-versus-host disease. [electronic resource] - International journal of hematology Sep 2009 - 253-260 p. digital
Publication Type: Clinical Trial; Clinical Trial, Phase II; Journal Article; Research Support, Non-U.S. Gov't
1865-3774
10.1007/s12185-009-0370-x doi
Adrenal Cortex Hormones--therapeutic use
Adult
Antibodies--blood
Antibodies, Monoclonal--administration & dosage
Antibodies, Monoclonal, Murine-Derived
Chronic Disease
Female
Graft vs Host Disease--drug therapy
Hematopoietic Stem Cell Transplantation--adverse effects
Humans
Immunologic Factors--administration & dosage
Male
Middle Aged
Prospective Studies
Rituximab
Transplantation, Homologous
Treatment Outcome
Young Adult
Rituximab for the treatment of corticosteroid-refractory chronic graft-versus-host disease. [electronic resource] - International journal of hematology Sep 2009 - 253-260 p. digital
Publication Type: Clinical Trial; Clinical Trial, Phase II; Journal Article; Research Support, Non-U.S. Gov't
1865-3774
10.1007/s12185-009-0370-x doi
Adrenal Cortex Hormones--therapeutic use
Adult
Antibodies--blood
Antibodies, Monoclonal--administration & dosage
Antibodies, Monoclonal, Murine-Derived
Chronic Disease
Female
Graft vs Host Disease--drug therapy
Hematopoietic Stem Cell Transplantation--adverse effects
Humans
Immunologic Factors--administration & dosage
Male
Middle Aged
Prospective Studies
Rituximab
Transplantation, Homologous
Treatment Outcome
Young Adult